Calretinin and other mesothelioma markers in synovial sarcoma: Analysis of antigenic similarities and differences with malignant mesothelioma

American Journal of Surgical Pathology

Volumn 25, Issue 5, 2001, Pages 610-617

  Miettinen, Markku ^a   Limon, Janusz ^b   Niezabitowski, Aleksander ^c   Lasota, Jerzy ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

BerEp4; HBME 1; Immunohistochemistry; Lung; Pleura; Sarcoma

Indexed keywords

BIOLOGICAL MARKER; CALRETININ; CD141 ANTIGEN; CD15 ANTIGEN; CYTOKERATIN 14; KERATIN; KERATIN 19; KERATIN 7; MESOTHELIOMA MARKER; PROTEIN BEREP4; UNCLASSIFIED DRUG; WILMS TUMOR PROTEIN 1;

ADULT; AGED; ANGIOSARCOMA; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; DIFFERENTIAL DIAGNOSIS; EPITHELIOID CELL; EPITHELIOID SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; PRESCHOOL CHILD; SPINDLE CELL; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD15; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CHILD; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MESOTHELIOMA; MIDDLE AGED; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; THROMBOMODULIN; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 0035002788     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200105000-00007     Document Type: Article

References (34)

1. Calretinin expression in ameloblastomas
2. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma
3. Mesothelioma-binding antibodies: Thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma
4. Calretinin - Sensor or buffer - Function still unclear
5. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance
6. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma
7. Keratin proteins and carcinoembryonic antigen in synovial sarcomas: An immunohistochemical study of 24 cases
8. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to pleura
9. Calretinin: A novel tool for diagnostic immunohistochemistry
10. Calretinin: A novel immunocytochemical marker for mesothelioma
11. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript
12. The calcium-binding protein calretinin 22k, an alternative splicing product of the calretinin gene is expressed in several colon adenocarcinoma cell lines
13. Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues
14. Primary synovial sarcoma of the lung: Report of two cases confirmed by molecular detection of SYT-SSX fusion gene transcript
15. Primary pulmonary sarcoma with morphologic features of monophasic synovial sarcoma and chromosome translocation t(X;18)
16. Cardiac synovial sarcoma with translocation (X;18) associated with asbestosis exposure
17. Detection of the SYT-SSX fusion transcript in formaldehyde-fixed, paraffin embedded tissue: A reverse transcription polymerase chain reaction assay useful in the diagnosis of synovial sarcoma
18. Cytogenetics of synovial sarcoma: Presentation of ten new cases and review of the literature
19. Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumors, recurrences and metastases
20. Patterns of keratin polypeptides in 110 biphasic, monophasic and poorly differentiated synovial sarcomas
21. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14
22. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
23. Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: A clinicopathological and immunohistochemical review of three cases
24. HBME-1, MOC-31, WT1 and calretinin: An assessment of recently described markers for mesothelioma and adenocarcinoma
25. The value of antibodies 44-3A6, SM3, HBME-1 and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: A comparative study with other commonly used antibodies
26. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma
27. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma
28. The immunohistochemical diagnostic panel for epithelial mesothelioma. A re-evaluation after heat-induced epitope retrieval
29. Synovial sarcoma: A new approach to the histological classification and comparison with malignant mesothelioma
30. Ber-Ep4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma
31. Classification, expression and possible mechanisms of evolution of mammalian epithelial keratins: A unifying model
32. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases
33. A biphasic tumor of the mediastinum with features of synovial sarcoma. A report of four cases
34. Primary pulmonary sarcomas with features of monophasic synovial sarcoma: A clinicopathological, immunohistochemical and ultrastructural study of 25 cases